Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
By Patrick Wingrove and Mariam Sunny (Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare neurological side effect was reported. The trial of the vaccine, dubbed mRNA-1403, was put on clinical hold following a single adverse event report of a …
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect Read More »









